Physician profile
David C Saypol
NPI 1568455640
$1,554.95
in general payments reported to CMS, 2019-2025
27 companies · $15.15 in 2025
The $15.15 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $213 · 2021: $158 · 2022: $477 · 2023: $315 · 2025: $15.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $330.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $358.96 | 2019-2023 | Erleada |
| Procept Biorobotics Corporation | $214.79 | 2021-2022 | |
| Astellas Pharma US INC | $187.77 | 2019-2023 | Myrbetriq |
| Pfizer INC. | $126.51 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $75.02 | 2019-2023 | Aveed, Xiaflex |
| Coloplast Corp | $63.50 | 2019-2025 | Speedicath |
| Dendreon Pharmaceuticals LLC | $60.25 | 2019-2020 | |
| Agiliti Surgical, INC. | $46.85 | 2023 | Trinity, Sonablate |
| Bayer Healthcare Pharmaceuticals INC. | $46.08 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $38.89 | 2022 | |
| Photocure INC | $30.01 | 2023 | Cysview |
| Sumitomo Pharma America, INC. | $29.67 | 2023 | Gemtesa |
| Urovant Sciences INC | $29.34 | 2022 | |
| Merck Sharp & Dohme LLC | $28.91 | 2019 | |
| Boston Scientific Corporation | $28.58 | 2020-2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $25.66 | 2019 | |
| Hollister Incorporated | $18.09 | 2023 | Vapro Pocket |
| Abbvie INC. | $16.31 | 2023 | Botox |
| Zyla Life Sciences, INC. | $15.29 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.00 | 2022 | |
| Metuchen Pharmaceuticals | $14.71 | 2019 | |
| Acerus Pharmaceuticals Corporation | $14.63 | 2022 | |
| Olympus America INC. | $14.61 | 2022 | |
| Blue Earth Diagnostics | $14.48 | 2020 | |
| Allergan, INC. | $13.89 | 2022 | |
| Ferring Pharmaceuticals INC. | $13.74 | 2019 | |
| Urogen Pharma, INC. | $13.41 | 2023 | Jelmyto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Saypol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.